4Filing Date: May 11, 2026
Edwards Lifesciences (EW) 4: Lippis Daniel J. sold 362 shares of Common Stock at $79.96… (May 11, 2026)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0001225208-26-005130
Total Value$28.9K
Trades1
Insiders1
Transaction Details
Lippis Daniel J.
CVP, TAVR·Direct
Tax W/H · Dispose
Common Stock
Shares-362
Price$79.96
Total Value$28.9K
Shares Owned After40.41K
Transaction DateMay 11, 2026
Post-Transaction Holdings
Lippis Daniel J. · CVP, TAVR
| Security | Shares | Change |
|---|---|---|
| Common Stock | 40.41K | -362 (-0.89%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-05-11
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: Edwards Lifesciences Corp (EW)
CIK: 0001099800
--- Reporting Owner ---
Name: Lippis Daniel J.
CIK: 0002004380
Role: Officer (CVP, TAVR)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: Common Stock
Date: 2026-05-11 | Code: F (Payment of exercise/tax)
Shares: -362 | Price: $79.96
Total Value: $28,945.52
Shares Owned After: 40,410.9103 | Ownership: D (Direct)
--- Signature ---
/s/ Linda J. Park, Attorney-in-Fact (2026-05-11)